Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,386 | -12,978 | -13,316 | -20,275 | -13,399 |
| Depreciation Amortization | 445 | 872 | 818 | 1,008 | 941 |
| Other Working Capital | -6,041 | 3,222 | -1,116 | 5,597 | 1,238 |
| Other Operating Activity | 7,207 | -1,670 | 763 | 698 | 940 |
| Operating Cash Flow | $-20,775 | $-10,554 | $-12,851 | $-12,972 | $-10,280 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -817 | -3,420 | N/A | N/A | N/A |
| PPE Investments | -37 | -146 | -160 | -509 | -82 |
| Purchase Sale Intangibles | N/A | -545 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -545 | 0 | -250 | 0 |
| Investing Cash Flow | $-854 | $-4,111 | $-160 | $-759 | $-82 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,488 | 3,292 | N/A | N/A | N/A |
| Debt Repayment | -5,542 | -3,996 | -1,608 | -1,608 | -276 |
| Common Stock Issued | 38,541 | 7,265 | 5,527 | 15,832 | 20,692 |
| Common Stock Repurchased | N/A | -374 | -126 | N/A | N/A |
| Other Financing Activity | -7,176 | 0 | -348 | -773 | 0 |
| Financing Cash Flow | $30,311 | $6,187 | $3,445 | $13,451 | $20,416 |
| Beginning Cash Position | 76 | 8,554 | 18,120 | 18,400 | 8,346 |
| End Cash Position | 8,758 | 76 | 8,554 | 18,120 | 18,400 |
| Net Cash Flow | $8,682 | $-8,478 | $-9,566 | $-280 | $10,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,775 | -10,554 | -12,851 | -12,972 | -10,280 |
| Capital Expenditure | -67 | -146 | -160 | -509 | -144 |
| Free Cash Flow | -20,842 | -10,700 | -13,011 | -13,481 | -10,424 |